Ramzi G Salloum1, Gail A Jensen, Andrea K Biddle. 1. Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, North Carolina, USA. ramzi.salloum@unc.edu
Abstract
BACKGROUND: On January 1, 2005, Medicare began covering a "Welcome to Medicare" visit (WMV) for new enrollees with fee-for-service (FFS) Medicare (Parts A and B). The new benefit was expected to increase demand for mammography and Pap tests among women transitioning onto Medicare. This study examined whether Medicare's coverage of a WMV influenced the use of mammography and Pap tests among women aged 65 and 66 years with FFS Medicare. METHODS: Medicare Current Beneficiary Survey (MCBS) data from 2001 to 2007 were linked with Medicare claims. Utilization rates for preventive visits, mammography, and Pap tests were measured among women entering Medicare. Multivariate logistic regressions were estimated to quantify the effects of the new Medicare benefit on the use of these screening tests, controlling for patient characteristics. RESULTS: Regression-adjusted mammography and Pap test rates did not increase after WMV coverage was introduced. The 2005 reform had nonsignificant trivial effects on the use of both tests, most likely because few of the women who were eligible for a WMV took advantage of it. CONCLUSIONS: Medicare coverage of a WMV had no impact on mammography screenings or Pap tests among women who were eligible for the benefit.
BACKGROUND: On January 1, 2005, Medicare began covering a "Welcome to Medicare" visit (WMV) for new enrollees with fee-for-service (FFS) Medicare (Parts A and B). The new benefit was expected to increase demand for mammography and Pap tests among women transitioning onto Medicare. This study examined whether Medicare's coverage of a WMV influenced the use of mammography and Pap tests among women aged 65 and 66 years with FFS Medicare. METHODS: Medicare Current Beneficiary Survey (MCBS) data from 2001 to 2007 were linked with Medicare claims. Utilization rates for preventive visits, mammography, and Pap tests were measured among women entering Medicare. Multivariate logistic regressions were estimated to quantify the effects of the new Medicare benefit on the use of these screening tests, controlling for patient characteristics. RESULTS: Regression-adjusted mammography and Pap test rates did not increase after WMV coverage was introduced. The 2005 reform had nonsignificant trivial effects on the use of both tests, most likely because few of the women who were eligible for a WMV took advantage of it. CONCLUSIONS: Medicare coverage of a WMV had no impact on mammography screenings or Pap tests among women who were eligible for the benefit.
Authors: Steven S Coughlin; Erica S Breslau; Trevor Thompson; Vicki B Benard Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-05 Impact factor: 4.254
Authors: Nancy Breen; Kathleen A Cronin; Helen I Meissner; Stephen H Taplin; Florence K Tangka; Jasmin A Tiro; Timothy S McNeel Journal: Cancer Date: 2007-06-15 Impact factor: 6.860
Authors: Chyke A Doubeni; Adeyinka O Laiyemo; Carrie N Klabunde; Angela C Young; Terry S Field; Robert H Fletcher Journal: Am J Prev Med Date: 2010-02 Impact factor: 5.043
Authors: Ramzi G Salloum; Racquel E Kohler; Gail A Jensen; Stacey L Sheridan; William R Carpenter; Andrea K Biddle Journal: J Womens Health (Larchmt) Date: 2013-11-06 Impact factor: 2.681
Authors: E Kathleen Adams; A Rana Bayakly; Alissa K Berzen; Sarah Blake; Peter Joski; Chunyu Li; Ingrid J Hall; Susan A Sabatino Journal: Cancer Causes Control Date: 2015-03-27 Impact factor: 2.506
Authors: Gregory S Cooper; Tzuyung D Kou; Mark D Schluchter; Avi Dor; Siran M Koroukian Journal: J Natl Cancer Inst Date: 2015-12-06 Impact factor: 13.506